Anika Therapeutics (ANIK) Stock Price, Quote & News

Company Profile

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products include Monovisc and Orthovisc, an injectable...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 781 457 9000

Fax: 781 305 9720

Website: www.anika.com

Address:

32 Wiggins Avenue, Bedford, United States

PippoBaudo Jun. 21 at 12:45 PM

$ANIK when the stupid Ceo is going to be kicked out???? Just remove is salary from the balance sheet and the company turns positive

0 · Reply

Rage_Against_The_Machine Jun. 18 at 9:37 PM

Anika's CINGAL gets spotlight in DelveInsight's osteoarthritis market report. With global OA cases projected to rise and $19B US market growing, $ANIK's viscosupplement tech could see tailwinds. But can they capitalize against fierce competition and their own revenue declines? https://www.prnewswire.com/news-releases/osteoarthritis-market-is-predicted-to-exhibit-remarkable-growth-during-the-forecast-period-20252034--delveinsight-302484831.html

0 · Reply

Dr_Stoxx Jun. 3 at 2:52 PM

If you missed the +13% 2-day move in $XNCR (so far), you might like this one: $ANIK. Strong buy from all analysts, PT consensus +83% above current price, strong volume, fresh MACD buy signal, rising RSI. Just a FYI...we were just talking about this one in the LIVE ROOM. Oh...and only 14M shares outstanding. I nibbled on a few myself. Holding $XNCR, same setup. Yeah, the chart is ugly...but the R/R is phenomenal.

1 · Reply

Sidoti May. 21 at 4:56 PM

Day 1: Presenting at 1:00pm at the virtual #SidotiConference $ANIK

0 · Reply

YouOnlyLiveTwice May. 14 at 3:02 PM

$ANIK This firm has been holding since the $50’s and each time they keep lowering the PT but keep “Outperform” lmao This company is trash …stay away until they fire the CEO

0 · Reply

JarvisFlow May. 12 at 12:00 PM

Barrington Research has updated their rating for Anika Therapeutics ( $ANIK ) to Outperform with a price target of 19.

0 · Reply

Fib7867 May. 10 at 11:01 PM

#myANIKanalysis $ANIK

0 · Reply

PippoBaudo May. 9 at 3:22 PM

$ANIK or they fire the ceo or this one is not going to end well

0 · Reply

YouOnlyLiveTwice May. 9 at 2:58 PM

$ANIK Short this to $10

0 · Reply

US_Bull May. 9 at 1:44 PM

$ANIK I was definitely wrong about this one for this Q.

0 · Reply

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 9, 2025, 11:51 AM EDT - 7 weeks ago

Anika Therapeutics, Inc. (ANIK) Q1 2025 Earnings Call Transcript

May 9, 2025, 7:05 AM EDT - 7 weeks ago

Anika Reports First Quarter 2025 Financial Results

May 7, 2025, 4:01 PM EDT - 7 weeks ago

Anika to Participate in the Sidoti Virtual Investor Conference

Apr 25, 2025, 9:00 AM EDT - 2 months ago

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

Mar 12, 2025, 5:55 PM EDT - 3 months ago

Anika Therapeutics, Inc. (ANIK) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 4:05 PM EDT - 3 months ago

Anika Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 7, 2025, 6:00 AM EST - 4 months ago

Anika Completes Divestiture of Parcus Medical

Feb 26, 2025, 8:00 AM EST - 4 months ago

Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025

Feb 25, 2025, 8:00 AM EST - 4 months ago

Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference

Dec 23, 2024, 4:01 PM EST - 6 months ago

Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

Nov 22, 2024, 4:16 PM EST - 7 months ago

Anika To Participate in December 2024 Investor Conferences

Nov 2, 2024, 9:41 PM EDT - 8 months ago

Anika Therapeutics, Inc. (ANIK) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 11:00 AM EDT - 8 months ago

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics

Oct 31, 2024, 7:05 AM EDT - 8 months ago

Anika Reports Third Quarter 2024 Financial Results

Oct 31, 2024, 7:00 AM EDT - 8 months ago

Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical

Oct 17, 2024, 4:01 PM EDT - 9 months ago

Anika Announces Third Quarter 2024 Results Conference Call Date

Aug 11, 2024, 1:49 AM EDT - 11 months ago

Anika Therapeutics, Inc (ANIK) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 11 months ago

Anika Reports Second Quarter 2024 Financial Results

Jul 25, 2024, 9:00 AM EDT - 1 year ago

Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Jul 11, 2024, 8:30 AM EDT - 1 year ago

Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs

Jul 1, 2024, 10:35 AM EDT - 1 year ago

Orthopedic Regenerative Surgical Products Market Size to Reach USD 6.6 Billion By 2033, at 4.4 CAGR: Insights by Dimension Market Research

May 28, 2024, 4:05 PM EDT - 1 year ago

Anika Enters into Cooperation Agreement with Caligan Partners

May 8, 2024, 11:36 PM EDT - 1 year ago

Anika Therapeutics, Inc. (ANIK) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:08 PM EDT - 1 year ago

Anika Announces CFO Transition

May 8, 2024, 4:05 PM EDT - 1 year ago

Anika Reports First Quarter 2024 Financial Results

Apr 18, 2024, 4:01 PM EDT - 1 year ago

Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024

Apr 2, 2024, 8:00 AM EDT - 1 year ago

Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Mar 13, 2024, 7:17 PM EDT - 1 year ago

Anika Therapeutics, Inc. (ANIK) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 4:05 PM EDT - 1 year ago

Anika Reports Fourth Quarter and Year-End 2023 Financial Results

Feb 27, 2024, 4:01 PM EST - 1 year ago

Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024

Feb 13, 2024, 9:00 AM EST - 1 year ago

Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting

Nov 28, 2023, 9:00 AM EST - 1 year ago

Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release

Nov 7, 2023, 4:05 PM EST - 1 year ago

Anika to Participate in Upcoming Investor Conferences

Nov 3, 2023, 4:34 PM EDT - 1 year ago

Anika Therapeutics, Inc. (ANIK) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 4:05 PM EDT - 1 year ago

Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business

Oct 10, 2023, 9:00 AM EDT - 1 year ago

Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023

Sep 19, 2023, 9:00 AM EDT - 1 year ago

Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting

Sep 12, 2023, 9:00 AM EDT - 1 year ago

Anika to Participate in the Sidoti Small Cap Virtual Investor Conference

Aug 17, 2023, 6:20 PM EDT - 2 years ago

Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs

Aug 8, 2023, 4:05 PM EDT - 2 years ago

Anika Reports Second Quarter 2023 Financial Results

Jul 20, 2023, 4:05 PM EDT - 2 years ago

Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

Jul 12, 2023, 9:00 AM EDT - 2 years ago

Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting

May 30, 2023, 4:05 PM EDT - 2 years ago

Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone

May 13, 2023, 12:23 PM EDT - 2 years ago

Anika Therapeutics Inc. (ANIK) Q1 2023 Earnings Call Transcript

May 9, 2023, 4:05 PM EDT - 2 years ago

Anika Reports First Quarter 2023 Financial Results

Apr 19, 2023, 8:30 AM EDT - 2 years ago

Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023

Apr 13, 2023, 5:00 PM EDT - 2 years ago

Anika Enters Into Cooperation Agreement with Caligan Partners

Apr 12, 2023, 9:00 AM EDT - 2 years ago

Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference

Apr 3, 2023, 9:00 AM EDT - 2 years ago

Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA

PippoBaudo Jun. 21 at 12:45 PM

$ANIK when the stupid Ceo is going to be kicked out???? Just remove is salary from the balance sheet and the company turns positive

0 · Reply

Rage_Against_The_Machine Jun. 18 at 9:37 PM

0 · Reply

Dr_Stoxx Jun. 3 at 2:52 PM

1 · Reply

Sidoti May. 21 at 4:56 PM

Day 1: Presenting at 1:00pm at the virtual #SidotiConference $ANIK

0 · Reply

YouOnlyLiveTwice May. 14 at 3:02 PM

$ANIK This firm has been holding since the $50’s and each time they keep lowering the PT but keep “Outperform” lmao This company is trash …stay away until they fire the CEO

0 · Reply

JarvisFlow May. 12 at 12:00 PM

Barrington Research has updated their rating for Anika Therapeutics ( $ANIK ) to Outperform with a price target of 19.

0 · Reply

Fib7867 May. 10 at 11:01 PM

#myANIKanalysis $ANIK

0 · Reply

PippoBaudo May. 9 at 3:22 PM

$ANIK or they fire the ceo or this one is not going to end well

0 · Reply

YouOnlyLiveTwice May. 9 at 2:58 PM

$ANIK Short this to $10

0 · Reply

US_Bull May. 9 at 1:44 PM

$ANIK I was definitely wrong about this one for this Q.

0 · Reply

US_Bull May. 9 at 1:11 PM

$ANIK Think their biggest problem is OEM channel pricing by J&J if they can get those prices up for monovisc and if they get approved for the FDA applied products for Cingal they can start to turn the corner.

0 · Reply

OpenOutcrier May. 9 at 12:29 PM

$ANIK (-7.5% pre) Anika Reports First Quarter 2025 Financial Results https://ooc.bz/l/64170

0 · Reply

YouOnlyLiveTwice May. 9 at 12:16 PM

$ANIK CEO says “Strong demand” Stock is down 48% in one year on horrible results but strong demand …lmao $10 next

1 · Reply

YouOnlyLiveTwice May. 7 at 11:11 PM

$ANIK wait for $10

2 · Reply

YouOnlyLiveTwice May. 7 at 11:11 PM

$ANIK Anybody buying here before the ER is asking for trouble. Their going have lots of costs associated w the 2 businesses they bought and destroyed . Furthermore they need to replace that revenue . Lastly the CEO is completely incompetent…..she has single handily destroyed this company but somehow retains CEO. She ran the CFO Mike out this new guy will be next

0 · Reply

Ttubular May. 5 at 10:49 AM

$ANIK earnings week who’s excited? I am expecting good #s!

1 · Reply

Ttubular May. 2 at 9:45 PM

$ANIK earnings soon. Can’t wait!! got a good feeling they’v

1 · Reply

US_Bull May. 2 at 12:50 PM

$ANIK Beat inbound in my opinion. Adding more today. Only way to go is up up up! Expectations lowered and they have divested their two businesses that were not performing.

1 · Reply

US_Bull Apr. 30 at 12:42 PM

$ANIK Not bad volume PM I think with the divestiture of Parcus, they are about to turn the corner this Q. Market cap should be higher than 200 million they do around 120$ million/year in revenues and have about 55$ million in cash and if they can get remaining products FDA approved growth will go up significantly IMO. I will add on any weakness.

0 · Reply

US_Bull Apr. 29 at 6:52 PM

$ANIK Too cheap market cap around 200 million is too low started a position.

0 · Reply

NVDAMillionaire Mar. 21 at 10:07 AM

$ANIK Digging ANIK's pivot. Regenerative solutions like Integrity looking promising. Commercial channel growth could be catalyst. Watching FDA approval for Hyalofast and Cingal closely. Potential long-term play if they execute strategy right. Might start building a small position. valuable article: https://beyondspx.com/article/anika-therapeutics-anik-a-pioneer-in-joint-preservation-and-regenerative-solutions

0 · Reply

StockTradeXLLC Mar. 17 at 10:07 AM

$ANIK / Anika Therapeutics files form 10-K <https://fintel.io/doc/sec-anika-therapeutics-inc-898437-10k-2025-march-17-20164-909?utm_source=

0 · Reply

Market Cap	154.02M
Revenue (ttm)	119.91M
Net Income (ttm)	-56.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-47.03%
Debt to Equity Ratio	0.00

Volume	196,600
Avg Vol	67,850
Day's Range	N/A - N/A
Shares Out	14.34M
Stochastic %K	28%
Beta	0.66
Analysts	Strong Sell
Price Target	$21.33